Lipocine Inc. (LPCN) stock
LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3037% below fair value
$1.60−0.06 (-3.61%)
Close on Nov 17, 2026Market cap $13.19MP/E –Yield –
Lipocine cash
Cash and short-term investments held at the end of each period.
Lipocine's cash was $23.27M at Jun 30, 2026. For fiscal 2025 it was $14.90M, down 31.1% from the year before. Over ten years it grew -2.9% a year on average. The highest annual figure on record is $45.26M in fiscal 2013.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.90M | -31.1% |
| FY2024 | Dec 31, 2024 | $21.63M | -1.8% |
| FY2023 | Dec 31, 2023 | $22.04M | -32.3% |
| FY2022 | Dec 31, 2022 | $32.53M | -27.1% |
| FY2021 | Dec 31, 2021 | $44.62M | +126.9% |
| FY2020 | Dec 31, 2020 | $19.67M | +3.1% |
| FY2019 | Dec 31, 2019 | $19.07M | -5.8% |
| FY2018 | Dec 31, 2018 | $20.25M | +54.9% |
| FY2017 | Dec 31, 2017 | $13.08M | +135.2% |
| FY2016 | Dec 31, 2016 | $5.56M | -72.2% |
| FY2015 | Dec 31, 2015 | $20.01M | -27.7% |
| FY2014 | Dec 31, 2014 | $27.67M | -38.9% |
| FY2013 | Dec 31, 2013 | $45.26M | +741.8% |
| FY2012 | Dec 31, 2012 | $5.38M | -37.2% |
| FY2011 | Dec 31, 2011 | $8.57M | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $23.27M | +29.7% |
| Q1 FY2026 | Mar 31, 2026 | $24.73M | +25.4% |
| Q4 FY2025 | Dec 31, 2025 | $14.90M | -31.1% |
| Q3 FY2025 | Sep 30, 2025 | $15.13M | -23.7% |
| Q2 FY2025 | Jun 30, 2025 | $17.94M | -20.5% |
| Q1 FY2025 | Mar 31, 2025 | $19.72M | -19.9% |
| Q4 FY2024 | Dec 31, 2024 | $21.63M | -1.8% |
| Q3 FY2024 | Sep 30, 2024 | $19.82M | -16.9% |
| Q2 FY2024 | Jun 30, 2024 | $22.55M | -12.6% |
| Q1 FY2024 | Mar 31, 2024 | $24.63M | -14.7% |
| Q4 FY2023 | Dec 31, 2023 | $22.04M | -32.3% |
| Q3 FY2023 | Sep 30, 2023 | $23.85M | -30.4% |
| Q2 FY2023 | Jun 30, 2023 | $25.79M | -31.0% |
| Q1 FY2023 | Mar 31, 2023 | $28.87M | -31.3% |
| Q4 FY2022 | Dec 31, 2022 | $32.53M | -27.1% |
| Q3 FY2022 | Sep 30, 2022 | $34.26M | -11.4% |
| Q2 FY2022 | Jun 30, 2022 | $37.40M | -19.8% |
| Q1 FY2022 | Mar 31, 2022 | $42.00M | -7.4% |
| Q4 FY2021 | Dec 31, 2021 | $44.62M | +126.9% |
| Q3 FY2021 | Sep 30, 2021 | $38.66M | +105.7% |
| Q2 FY2021 | Jun 30, 2021 | $46.64M | +154.8% |
| Q1 FY2021 | Mar 31, 2021 | $45.35M | +120.3% |
| Q4 FY2020 | Dec 31, 2020 | $19.67M | +3.1% |
| Q3 FY2020 | Sep 30, 2020 | $18.80M | +13.6% |
| Q2 FY2020 | Jun 30, 2020 | $18.30M | +111.3% |
| Q1 FY2020 | Mar 31, 2020 | $20.58M | +150.3% |
| Q4 FY2019 | Dec 31, 2019 | $19.07M | -5.8% |
| Q3 FY2019 | Sep 30, 2019 | $16.55M | – |
| Q2 FY2019 | Jun 30, 2019 | $8.66M | +31.2% |
| Q1 FY2019 | Mar 31, 2019 | $8.22M | -4.0% |
| Q4 FY2018 | Dec 31, 2018 | $20.25M | +54.9% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $6.60M | -60.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.56M | +23.4% |
| Q4 FY2017 | Dec 31, 2017 | $13.08M | +135.2% |
| Q3 FY2017 | Sep 30, 2017 | $9.27M | +97.0% |
| Q2 FY2017 | Jun 30, 2017 | $16.63M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.94M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.71M | – |
See a number that looks wrong?